Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort

BACKGROUND: Identifying subjects with chronic obstructive pulmonary disease (COPD) at high risk of exacerbation and mortality is key to aid individual management of COPD. The only FDA approved blood-based drug development biomarker for patients at high risk of mortality, is plasma fibrinogen. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rønnow, Sarah Rank, Sand, Jannie Marie Bülow, Langholm, Lasse Løcke, Manon-Jensen, Tina, Karsdal, Morten Asser, Tal-Singer, Ruth, Miller, Bruce E., Vestbo, Jørgen, Leeming, Diana Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444812/
https://www.ncbi.nlm.nih.gov/pubmed/30935391
http://dx.doi.org/10.1186/s12931-019-1026-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444812/
https://www.ncbi.nlm.nih.gov/pubmed/30935391
http://dx.doi.org/10.1186/s12931-019-1026-x

Ejemplares similares